{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:06:21Z","timestamp":1790057181719,"version":"4.0.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.revmed.2017.03.007","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T03:01:04Z","timestamp":1493348464000},"page":"663-669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["\u00c9pid\u00e9miologie et histoire naturelle de l\u2019art\u00e9rite \u00e0 cellules g\u00e9antes (Horton)"],"prefix":"10.1016","volume":"38","author":[{"given":"A.","family":"Mahr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aouba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Richeb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gonzalez-Chiappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2017.03.007_bib0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F","article-title":"Disease pattern in cranial and large-vessel giant cell arteritis","volume":"42","author":"Brack","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0010","first-page":"182","article-title":"Extracranial giant cell arteritis: a narrative review","volume":"74","author":"Lensen","year":"2016","journal-title":"Neth J Med"},{"key":"10.1016\/j.revmed.2017.03.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew273","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","author":"Dejaco","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/rheumatology\/keu329","article-title":"Large-vessel giant cell arteritis: a cohort study","volume":"54","author":"Muratore","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.revmed.2015.12.015","article-title":"Management of giant cell arteritis: recommendations of the French study group for large vessel vasculitis (GEFA)","volume":"37","author":"Bienvenu","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.03.007_bib0030","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.autrev.2016.02.016","article-title":"Comparison of idiopathic (isolated) aortitis and giant cell arteritis-related aortitis. A French retrospective multicenter study of 117\u00a0patients","volume":"15","author":"Espitia","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"3\u00a0Suppl. 82","key":"10.1016\/j.revmed.2017.03.007_bib0040","first-page":"S55","article-title":"Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin?","volume":"32","author":"Talarico","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0045","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/art.1780261007","article-title":"The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee","volume":"26","author":"Smith","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bjo.2009.177220","article-title":"Giant cell arteritis in Asians: a comparative study","volume":"95","author":"Pereira","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0055","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0161-6420(01)00574-7","article-title":"The epidemiology of giant cell arteritis: a 12-year retrospective study","volume":"108","author":"Liu","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2017.03.007_bib0060","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.11195","article-title":"Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998\u00a0in Japan: the first government-supported nationwide survey","volume":"49","author":"Kobayashi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/bjo.2006.108845","article-title":"Epidemiology of giant-cell arteritis in an Arab population: a 22-year study","volume":"91","author":"Chaudhry","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"4\u00a0Suppl. 20","key":"10.1016\/j.revmed.2017.03.007_bib0070","first-page":"S9","article-title":"Epidemiology of polymyalgia rheumatica","volume":"18","author":"Cimmino","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/03009740310003992","article-title":"No major differences in incidence of temporal arteritis in northern and western Norway compared with reports from southern Norway","volume":"32","author":"Haugeberg","year":"2003","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0080","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/rheumatology\/41.5.540","article-title":"No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register","volume":"41","author":"Reinhold-Keller","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0085","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/rheumatology\/39.12.1396","article-title":"Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany","volume":"39","author":"Reinhold-Keller","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.revmed.2015.10.256","article-title":"Mortalit\u00e9 associ\u00e9e \u00e0 l\u2019art\u00e9rite \u00e0 cellules g\u00e9antes (Horton) en France pour la p\u00e9riode 1980\u20132011\u00a0: analyse de la base de donn\u00e9es C\u00e9piDC","volume":"36","author":"Gonzalez-Chiappe","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.03.007_bib0095","first-page":"1694","article-title":"Trends in the incidence of polymyalgia rheumatica over a 30\u00a0year period in Olmsted County, Minnesota USA","volume":"29","author":"Doran","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0100","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2005.046912","article-title":"Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990\u20132001","volume":"65","author":"Smeeth","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0105","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/38.12.1208","article-title":"The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations","volume":"38","author":"Petursdottir","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2133.1965.tb14630.x","article-title":"The aetiology pathology and course of giant-cell arteritis. The possible role of light sensitivity","volume":"77","author":"Kinmont","year":"1965","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0115","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/rheumatology\/33.10.938","article-title":"Giant cell arteritis in Jerusalem: a 12-year epidemiological study","volume":"33","author":"Sonnenblick","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/003693307902400203","article-title":"Temporal arteritis. A 14-year epidemiological, clinical and prognostic study","volume":"24","author":"Jonasson","year":"1979","journal-title":"Scott Med J"},{"key":"10.1016\/j.revmed.2017.03.007_bib0125","first-page":"1524","article-title":"Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis","volume":"20","author":"Raynauld","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/ard.51.2.186","article-title":"Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands","volume":"51","author":"Steven","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard.58.6.335","article-title":"Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de recherche sur l\u2019art\u00e9rite a cellules g\u00e9antes","volume":"58","author":"Duhaut","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0140","first-page":"241","article-title":"Epidemiology of temporal arteritis in Israel","volume":"18","author":"Friedman","year":"1982","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.revmed.2017.03.007_bib0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/03009749309095141","article-title":"Incidence and survival rate in cases of biopsy-proven temporal arteritis","volume":"22","author":"Rajala","year":"1993","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/rheumatology\/keg116","article-title":"Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment","volume":"42","author":"Nordborg","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0155","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/annrheumdis-2013-204652","article-title":"Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden","volume":"74","author":"Mohammad","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","article-title":"Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study","volume":"86","author":"Gonzalez-Gay","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0248-8663(82)80003-9","article-title":"Epidemiologic approach to Horton's disease in the department of Loire-Atlantique. 110\u00a0cases in 10\u00a0years (1970\u20131979)","volume":"3","author":"Barrier","year":"1982","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.03.007_bib0170","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/acr.22942","article-title":"Incidence, prevalence and survival of biopsy-proven giant cell arteritis in Northern Italy during a 26-year period","volume":"69","author":"Catanoso","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1\u00a0Suppl. 44","key":"10.1016\/j.revmed.2017.03.007_bib0175","first-page":"S15","article-title":"The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations","volume":"25","author":"Bas-Lando","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0180","first-page":"830","article-title":"Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: clinical features and epidemiological data","volume":"27","author":"Pamuk","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/imj.12293","article-title":"Epidemiology of biopsy-proven giant cell arteritis in South Australia","volume":"44","author":"Dunstan","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.revmed.2017.03.007_bib0190","first-page":"44","article-title":"The epidemiology of giant cell arteritis in Otago. New Zealand: a 9-year analysis","volume":"124","author":"Abdul-Rahman","year":"2011","journal-title":"N Z Med J"},{"key":"10.1016\/j.revmed.2017.03.007_bib0195","first-page":"94","article-title":"Distribution of HLA-DRB1\u00a0alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population","volume":"25","author":"Combe","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0200","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.57.6.380","article-title":"Relation between HLA-DRB1\u00a0alleles and corticosteroid resistance in giant cell arteritis","volume":"57","author":"Rauzy","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0205","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","article-title":"Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis","volume":"121","author":"Weyand","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2017.03.007_bib0210","first-page":"2148","article-title":"Mannose-binding lectin variant alleles and HLA-DR4\u00a0alleles are associated with giant cell arteritis","volume":"29","author":"Jacobsen","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0215","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.semarthrit.2003.12.001","article-title":"HLA-DRB1\u00a0allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis","volume":"34","author":"Martinez-Taboda","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0220","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.1780310515","article-title":"Polymyalgia rheumatica: a syndrome associated with HLA-DR4\u00a0antigen","volume":"31","author":"Cid","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0225","first-page":"2140","article-title":"Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association","volume":"25","author":"Dababneh","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0230","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajhg.2016.11.013","article-title":"A genome-wide association study identifies risk alleles in plasminogen and P4HA2\u00a0associated with giant cell arteritis","volume":"100","author":"Carmona","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.revmed.2017.03.007_bib0235","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K","article-title":"Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms","volume":"43","author":"Mattey","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0240","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N","article-title":"Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions","volume":"43","author":"Cid","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0245","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1002\/art.22218","article-title":"Interleukin-10\u00a0promoter polymorphisms in giant cell arteritis","volume":"54","author":"Boiardi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0250","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/1529-0131(200011)43:11<2472::AID-ANR14>3.0.CO;2-B","article-title":"Vascular endothelial growth factor production in polymyalgia rheumatica","volume":"43","author":"Meliconi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0255","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","article-title":"Correlation of interleukin-6\u00a0production and disease activity in polymyalgia rheumatica and giant cell arteritis","volume":"36","author":"Roche","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0260","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1136\/annrheumdis-2013-203641","article-title":"Identification of the PTPN22\u00a0functional variant R620W as susceptibility genetic factor for giant cell arteritis","volume":"72","author":"Serrano","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0265","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13075-015-0692-4","article-title":"Association of HLA-DRB1\u00a0amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation","volume":"17","author":"Mackie","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2017.03.007_bib0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780170105","article-title":"Familial aggregation of polymyalgia rheumatica and giant cell arteritis","volume":"17","author":"Liang","year":"1974","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0275","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1755-3768.1977.tb01299.x","article-title":"Monozygotic twins with temporal arteritis and ophthalmic arteriti","volume":"55","author":"Kemp","year":"1977","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/ar3358","article-title":"Giant cell arteritis: immune and vascular aging as disease risk factors","volume":"13","author":"Mohan","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2017.03.007_bib0285","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3899\/jrheum.140906","article-title":"Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study","volume":"42","author":"Pugnet","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0290","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3899\/jrheum.151024","article-title":"Which patients with giant cell arteritis will develop cardiovascular or cerebrovascular disease? A clinical practice research datalink study","volume":"43","author":"Robson","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0295","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X","article-title":"Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de recherche sur l\u2019art\u00e9rite a cellules g\u00e9antes","volume":"41","author":"Duhaut","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0300","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/keu331","article-title":"Body mass index and the risk of giant cell arteritis: results from a prospective study","volume":"54","author":"Jakobsson","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0305","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2005.039404","article-title":"Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis","volume":"65","author":"Larsson","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0310","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/ije\/18.4.836","article-title":"A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease?","volume":"18","author":"Machado","year":"1989","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0315","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/M12-3046","article-title":"Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study","volume":"160","author":"Tomasson","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2017.03.007_bib0320","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3899\/jrheum.121150","article-title":"Statin use in giant cell arteritis: a retrospective study","volume":"40","author":"Schmidt","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0325","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/acr.22416","article-title":"Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study","volume":"67","author":"Udayakumar","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0330","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.revmed.2005.10.009","article-title":"Incidence des accidents cardiovasculaires au cours de la maladie de Horton\u00a0: r\u00e9sultats pr\u00e9liminaires de l\u2019\u00e9tude prospective en double cohorte GRACG","volume":"27","author":"Le Page","year":"2006","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.03.007_bib0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/rheumatology\/kev262","article-title":"Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study","volume":"55","author":"Amiri","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0340","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/WNL.0000000000001409","article-title":"Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis","volume":"84","author":"Gilden","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2017.03.007_bib0345","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaneurol.2015.0840","article-title":"Successful antiviral treatment of giant cell arteritis and Takayasu arteritis","volume":"72","author":"Gilden","year":"2015","journal-title":"JAMA Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.revmed.2017.03.007_bib0350","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/annrheumdis-2016-eular.4888","article-title":"Analysis of varicella-zoster virus in temporal artery biopsies positive and negative for giant cell arteritis","volume":"75","author":"Muratore","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0355","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/01.wnl.0000475335.63503.86","article-title":"Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis","volume":"85","author":"Lavi","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2017.03.007_bib0360","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/rheumatology\/38.2.118","article-title":"Giant cell arteritis and polymyalgia rheumatica: are pregnancies a protective factor? A prospective, multicentre case-control study. GRACG (Groupe de recherche sur l\u2019art\u00e9rite a cellules g\u00e9antes)","volume":"38","author":"Duhaut","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0365","first-page":"232","article-title":"Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis","volume":"3","author":"Ungprasert","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.revmed.2017.03.007_bib0370","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semarthrit.2016.08.015","article-title":"Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis","volume":"46","author":"Hill","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0375","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/rheumatology\/keu303","article-title":"Mortality in patients with giant cell arteritis","volume":"54","author":"Baslund","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0380","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/annrheumdis-2013-204113","article-title":"The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0385","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.1780371020","article-title":"Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41\u00a0cases","volume":"37","author":"Evans","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0390","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","article-title":"Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis","volume":"72","author":"Kermani","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0395","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1136\/annrheumdis-2013-203322","article-title":"Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation)","volume":"73","author":"Garcia-Martinez","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0400","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.semarthrit.2016.07.005","article-title":"Cerebrovascular accident in patients with giant cell arteritis: a systematic review and meta-analysis of cohort studies","volume":"46","author":"Ungprasert","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0405","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/1756-185X.12631","article-title":"Peripheral arterial disease in patients with giant cell arteritis: a meta-analysis","volume":"19","author":"Ungprasert","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0410","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.semarthrit.2014.10.010","article-title":"Coronary artery disease in giant cell arteritis: a systematic review and meta-analysis","volume":"44","author":"Ungprasert","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0415","first-page":"737","article-title":"Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden","volume":"29","author":"Uddhammar","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0420","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar2664","article-title":"Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study","volume":"11","author":"Warrington","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2017.03.007_bib0425","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/03009740310000382","article-title":"Causes of death in polymyalgia rheumatica. A prospective longitudinal study of 315\u00a0cases and matched population controls","volume":"32","author":"Myklebust","year":"2003","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0430","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/40.11.1238","article-title":"Survival in polymyalgia rheumatica and temporal arteritis: a study of 398\u00a0cases and matched population controls","volume":"40","author":"Gran","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0435","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/acr.21569","article-title":"Incidence of infections in patients with giant cell arteritis: a cohort study","volume":"64","author":"Durand","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0440","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/art.39596","article-title":"Incidence of severe infections and infection-related mortality during the course of giant cell arteritis: a multicenter, prospective double-cohort study","volume":"68","author":"Schmidt","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0445","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semarthrit.2014.06.004","article-title":"Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis","volume":"44","author":"Ungprasert","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0450","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/03009742.2014.982701","article-title":"The incidence of giant cell arteritis in Olmsted County. Minnesota, over a 60-year period 1950\u20132009","volume":"44","author":"Chandran","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0455","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/acr.22429","article-title":"Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities","volume":"67","author":"Petri","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.revmed.2017.03.007_bib0460","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.20928","article-title":"Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register","volume":"53","author":"Reinhold-Keller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0465","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/art.1780300308","article-title":"Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982\u20131985","volume":"30","author":"Boesen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0470","first-page":"112","article-title":"Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection","volume":"23","author":"Elling","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0475","first-page":"273","article-title":"Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984\u20131988","volume":"19","author":"Franzen","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0480","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780370705","article-title":"Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis","volume":"37","author":"Baldursson","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0485","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard.2004.022335","article-title":"Incidence of primary systemic vasculitides in Vilnius: a university hospital population based study","volume":"64","author":"Dadoniene","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0490","first-page":"1739","article-title":"The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987\u201394","volume":"24","author":"Gran","year":"1997","journal-title":"J Rheumatol"},{"issue":"Suppl. 2","key":"10.1016\/j.revmed.2017.03.007_bib0495","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/annrheumdis-2014-eular.3850","article-title":"The incidence rate of giant cell arteritis in southern norway is lower than previous reported: a result of temporal variations or a sign of a true shift in incidence rates?","volume":"73","author":"Diamantopoulos","year":"2014","journal-title":"Annals Rheum Dis"},{"key":"10.1016\/j.revmed.2017.03.007_bib0500","first-page":"295","article-title":"Giant cell arteritis in a neuro-ophthalmology clinic in Saskatoon, 1998\u20132003","volume":"42","author":"Ramstead","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0505","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.20227","article-title":"Reappraisal of the epidemiology of giant cell arteritis in Olmsted County. Minnesota, over a fifty-year period","volume":"51","author":"Salvarani","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.03.007_bib0510","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3129\/i08-164","article-title":"Giant cell arteritis in Alaska natives","volume":"44","author":"Mader","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.03.007_bib0515","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3899\/jrheum.150557","article-title":"The incidence of primary systemic vasculitis in Jerusalem: A 20-year hospital-based retrospective study","volume":"43","author":"Nesher","year":"2016","journal-title":"J Rheumatol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317301005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317301005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:37:43Z","timestamp":1759336663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866317301005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":103,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0248866317301005"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2017.03.007","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9pid\u00e9miologie et histoire naturelle de l\u2019art\u00e9rite \u00e0 cellules g\u00e9antes (Horton)","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2017.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}